Anti-Phosphatidylethanolamine and Anti-Phosphatidylserine Antibodies—Association with Renal Involvement, Atherosclerosis, Cardiovascular Manifestations, Raynaud Phenomenon and Disease Activity in Polish Patients with Systemic Lupus Erythematosus

Objective. To evaluate the association between anti-phosphatidylethanolamine (aPE) and anti-phosphatidylserine (aPS) antibodies and cardiovascular risk, organ involvement and disease activity in systemic lupus erythematosus (SLE) patients. Methods. We studied 93 SLE patients and 30 controls. We anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Katarzyna, Przepiera-Będzak, Hanna, Brzosko, Iwona, Sawicki, Marcin, Walecka, Anna, Brzosko, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599205/
https://www.ncbi.nlm.nih.gov/pubmed/36291537
http://dx.doi.org/10.3390/biom12101328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599205/
https://www.ncbi.nlm.nih.gov/pubmed/36291537
http://dx.doi.org/10.3390/biom12101328

Ejemplares similares